IL-4 administration exerts preventive effects via suppression of underlying inflammation and TNF-α-induced apoptosis

X Wu1, X Feng1, Y He1

  • 1Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Abstract

Insights

Interleukin-4 (IL-4) therapy effectively combats steroid-induced osteonecrosis in mice by modulating macrophage polarization and reducing osteocyte apoptosis. This approach shows promise for preventing this debilitating bone disease.

Area of Science:

  • Immunology
  • Orthopedics
  • Molecular Biology

Background:

  • Steroid-induced osteonecrosis (ON) is characterized by macrophage infiltration into necrotic bone sites.
  • Understanding macrophage polarization is crucial for developing effective ON treatments.

Purpose of the Study:

  • To investigate the therapeutic effects of Interleukin-4 (IL-4) on macrophage polarization in steroid-induced ON.
  • To elucidate the signaling pathways involved in IL-4's protective mechanisms.

Main Methods:

  • Steroid-induced ON model established in BALB/c mice using methylprednisolone (MPS).
  • Treatment group received daily rIL-4 injections for five days post-MPS administration.
  • Analysis included histopathology, ELISA, immunohistochemistry, TUNEL assay, and assessment of STAT1 and caspase-3 signaling.

Main Results:

  • IL-4 administration reduced ON incidence, osteoclast accumulation, and TNF-α expression.
  • IL-4 shifted macrophage phenotype from M1 to M2, decreasing inflammation.
  • IL-4 significantly reduced osteocyte apoptosis via the STAT1-caspase-3 pathway.

Conclusions:

  • IL-4 alleviates steroid-associated ON by inhibiting inflammation and M1 macrophage infiltration.
  • IL-4 suppresses TNF-α-induced osteocyte apoptosis through the STAT1-caspase-3 signaling pathway.
  • IL-4 demonstrates therapeutic potential for preventing steroid-induced osteonecrosis.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
738
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
663
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
18.9K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
620
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
931